Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy.

MLA

Miller, Jessa E., et al. “Determining the Minimal Clinically Important Difference for the Questionnaire of Olfactory Disorders in People with Cystic Fibrosis and Factors Associated with Improvement after Highly Effective Modulator Therapy.” International Forum of Allergy & Rhinology, vol. 14, no. 6, June 2024, pp. 1079–87. EBSCOhost, https://doi.org/10.1002/alr.23312.

APA

Miller, J. E., Taylor, C. J. L., Overdevest, J. B., Khatiwada, A., Mace, J. C., Alt, J. A., Bodner, T. E., Chowdhury, N. I., DiMango, E. A., Eshaghian, P. H., Getz, A. E., Gudis, D. A., Han, E. J., Hwang, P. H., Keating, C. L., Khanwalkar, A., Kimple, A. J., Lee, J. T., Li, D., & Markarian, K. (2024). Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy. International Forum of Allergy & Rhinology, 14(6), 1079–1087. https://doi.org/10.1002/alr.23312

Chicago

Miller, Jessa E., Cousar, Jennifer L. Taylor, Jonathan B. Overdevest, Aastha Khatiwada, Jess C. Mace, Jeremiah A. Alt, Todd E. Bodner, et al. 2024. “Determining the Minimal Clinically Important Difference for the Questionnaire of Olfactory Disorders in People with Cystic Fibrosis and Factors Associated with Improvement after Highly Effective Modulator Therapy.” International Forum of Allergy & Rhinology 14 (6): 1079–87. doi:10.1002/alr.23312.